✦ LIBER ✦

The addition of mibefradil to chronic hydrochlorothiazide therapy in hypertensive patients is associated with a significant antihypertensive effect

✍ Scribed by Carney, S; Wing, L; Ribeiro, A; Kallwellis, R; Zimlichman, R; Viskoper, R J; Jr, D Mion; Kobrin, I

Book ID: 110047627
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 277 KB
Volume: 11
Category: Article
ISSN: 0950-9240
DOI: 10.1038/sj.jhh.1000465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Naloxone does not antagonize the antihyp

Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients

✍ G. P. Bernini; A. R. Lucarini; M. S. Vivaldi; C. Del Corso; M. Lenzi; A. Salvett 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 382 KB

Progesterone receptor is a significant f

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

✍ Shuzhen Liu; Stephen K. Chia; Erika Mehl; Samuel Leung; Ashish Rajput; Maggie C. 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 415 KB

Freehand three-dimensional echocardiogra

Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study

✍ Galzerano, D; Tammaro, P; Cerciello, A; Breglio, R; Mallardo, M; Lama, D; Tuccil 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Pilot study of lonafarnib, a farnesyl tr

Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy

✍ Gautam Borthakur; Hagop Kantarjian; George Daley; Moshe Talpaz; Susan O'Brien; G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

A mutation in the interferon sensitivity

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b

✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon

Is it possible to discontinue imatinib m

Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature

✍ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o